Search

Your search keyword '"Salama MM"' showing total 160 results

Search Constraints

Start Over You searched for: Author "Salama MM" Remove constraint Author: "Salama MM"
160 results on '"Salama MM"'

Search Results

1. Chemerin As A Non-Invasive Serum Marker for Non-Alcoholic Fatty Liver Disease

2. Portal venous and hepatic artery hemodynamic variation in non-alcoholic fatty liver disease

3. Correlation of serum betatrophin levels with disease severity and the emergence of insulin resistance in cirrhotic patients

4. MYOSTATIN LEVEL IN CRF PATIENTS WITH AND WITHOUT POST-HCV CIRRHOSIS AND ITS CORRELATION WITH BMI

5. Role of Serum Leptin in the Diagnosis and Prognosis of Hepatocellular Carcinoma in Egyptian Cirrhotic Patients

6. Comparison between NAFLD fibrosis score and retinoic acid serum level in NAFLD

7. Value of Plasma Squamous Cell Carcinoma Antigen-IgM Immune Complexes (SCCA-IgM IC) as a Novel Biomarker for Monitoring Hepatocellular Carcinoma Treatment Outcome

8. Relationship of serum vaspin, nafld fibrosis score to ultrasonographic detection and quantification of steatosis in nonalcoholic fatty liver disease patients

9. Usefulness of AF Lactoferrin Levels in Patients with Liver Cirrhosis to Diagnose Spontaneous Bacterial Peritonitis

10. Assessment of myostatin in obese males and females with and without fatty liver

11. A study of procalcitonin and c-reactive protein in chronic h.pylori gastritis and it’s relation to severity of the disease

12. Evaluation of plasma M2-Pyruvate Kinase as a novel biomarker in the differentiation between Functional and Organic Colonic Disorders

13. Vascular Endothelial growth factor A in HCV infected patients before and after treatment with DAAS and its possible relation to HCC development

14. Predictive value of serum chemerin and nafld fibrosis score to ultrasonographic detection and quantification of steatosis in nonalcoholic fatty liver disease patients

15. Vascular endothelial growth factor in relation to the development of hepatocellular carcinoma in hepatitis C virus patients treated by direct-acting antivirals

16. Evaluation of microRNA-34a as a molecular link between insulin resistance and nonalcoholic fatty liver disease

17. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals

19. Sofosbuvir Plus Daclatasvir in Treatment of Chronic Hepatitis C Genotype 4 Infection in a Cohort of Egyptian Patients: An Experiment the Size of Egyptian Village

21. In vitro anti-influenza virus activity of a cardiotonic glycoside from Adenium obesum (Forssk.)

22. The Optimal Approach to Surgical Management of Goblet Cell Carcinoid of the Appendix: A Systematic Review.

23. Cell cycle machinery in oncology: A comprehensive review of therapeutic targets.

24. Bioinformatics approach for structure modeling, vaccine design, and molecular docking of Brucella candidate proteins BvrR, OMP25, and OMP31.

25. Rosemary and neem: an insight into their combined anti-dandruff and anti-hair loss efficacy.

26. The Potential of Natural Products in the Management of COVID-19.

28. Novel phloretin-based combinations targeting glucose metabolism in hepatocellular carcinoma through GLUT2/PEPCK axis of action: in silico molecular modelling and in vivo studies.

29. Nanotechnology in leukemia: diagnosis, efficient-targeted drug delivery, and clinical trials.

30. A novel lupene derivative from Thymus capitatus possesses an apoptosis-inducing effect via Let-7 miRNA/Cyclin D1/VEGF cascade in the A549 cell line.

31. Experimental investigation on a thermochemical seasonal sorption energy storage battery utilizing MgSO 4 -H 2 O.

32. Anti-Obesity Effect of a Tea Mixture Nano-Formulation on Rats Occurs via the Upregulation of AMP-Activated Protein Kinase/Sirtuin-1/Glucose Transporter Type 4 and Peroxisome Proliferator-Activated Receptor Gamma Pathways.

33. Endoscopic third ventriculostomy for management of hydrocephalus associated with Chiari malformation type II in children.

34. Diminished choroidal blood flow in hypertensive and preeclamptic third trimester pregnancies using optical coherence tomography angiography.

35. Clinical evaluation of thermo-viscous and sonic fill-activated bulk fill composite restorations.

36. Comparative metabolite profiling of four polyphenol rich Morus leaves extracts in relation to their antibiofilm activity against Enterococcus faecalis.

37. Trocar-assisted flanged transconjunctival intrascleral sutureless intraocular lens fixation.

38. Short-term effect of weight loss after bariatric surgery on IOP, RNFL thickness, and the optic nerve head blood flow measured by OCTA.

39. Endothelial Cell Loss, Cumulative Dissipated Energy, and Surgically Induced Astigmatism in Sutureless Scleral Tunnel Phaco-Assisted Cataract Extraction in Advanced Cataracts.

40. Non-polar metabolites of green beans (Phaseolus vulgaris L.) potentiate the antidiabetic activity of mesenchymal stem cells in streptozotocin-induced diabetes in rats.

41. Phenolics from Physalis peruviana fruits ameliorate streptozotocin-induced diabetes and diabetic nephropathy in rats via induction of autophagy and apoptosis regression.

42. Bioinformatics Analysis of Allele Frequencies and Expression Patterns of ACE2, TMPRSS2 and FURIN in Different Populations and Susceptibility to SARS-CoV-2.

43. Downregulation of MMP1 expression mediates the anti-aging activity of Citrus sinensis peel extract nanoformulation in UV induced photoaging in mice.

44. Cattleianal and Cattleianone: Two New Meroterpenoids from Psidium cattleianum Leaves and Their Selective Antiproliferative Action against Human Carcinoma Cells.

45. Anti-estrogenic and anti-aromatase activities of citrus peels major compounds in breast cancer.

46. Combination of pomegranate extract and curcumin ameliorates thioacetamide-induced liver fibrosis in rats: impact on TGF-β/Smad3 and NF-κB signaling pathways.

48. A Novel Biochemical Study of Anti-Ageing Potential of Eucalyptus Camaldulensis Bark Waste Standardized Extract and Silver Nanoparticles.

49. Dual inhibition of glycolysis and autophagy as a therapeutic strategy in the treatment of Ehrlich ascites carcinoma.

50. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals.

Catalog

Books, media, physical & digital resources